Medicure (TSE:MPH) has released an update.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Medicure Inc. has completed the acquisition of intellectual property from CanAm Bioresearch, securing new chemical entities that could revolutionize disease treatment pending further studies and regulatory approval. The deal includes initial cash payment and milestone payments, plus a share of future net proceeds relating to the assets, indicating a strong potential for future revenue growth.
For further insights into TSE:MPH stock, check out TipRanks’ Stock Analysis page.